Operates cord blood stem cell banks, and has supplied more than 1,400 cord blood products for more than 40 life-threatening diseases to more than 250 worldwide transplant centers. The company is actively involved in the development of new umbilical cord blood-based cell therapies. In addition, StemCyte offers private umbilical cord blood banking services to families to process and store their childs cord blood.
Ewing, New Jersey
Inc. 5000 Rankings
No. 3442 (2011), No. 2618 (2010)
WebsiteData as of Publication on Aug. 11, 2020